London's Savile Row was turned into a sheep field today, to highlight The Campaign For Wool; a coalition of industry groups convened by HRH The Prince of Wales to educate consumers about the benefits of wool.
As the sheep grazed, the Row's famous tailoring houses held events where the public could find out more about the natural, sustainable qualities of wool.
Douglas Cordeaux, Managing Director of West Country woollen mill Fox Brothers, one of the organisations behind the promotion said: "We have a collective responsibility to champion this versatile, sustainable and natural fibre, the production of which involves far lower carbon emissions than man‐made alternatives. We need to support farmers who are the custodians of our rural landscape and truly value the qualities of this wonderful resource, which is used to weave the finest luxury cloth you can buy."
John Thorley of the Campaign for Wool said: 'I'd like to see wool re-established as a fibre of consequence where workers get paid properly and people recognise that this animal is useful to the farming sector in a multitude of ways.'
For more information, see www.campaignforwool.org and www.savilerowfieldday.com
FMDMost of you will be aware that IP8 was declared yesterday. This is a farm in the POZ that was slaughtered on suspicion after detection during surveillance visits. This has lead to further slight changes in the boundaries of the PZ and SZ. These were early lesions and initial laboratory results confirm this.
The epidemiology of the spread of FMD in the area north of Egham suggests that cattle on 4 premises in the vicinity of IP8 have been exposed to infection either via possible aerosol or fomite spread and are likely to develop disease. These premises will be culled as dangerous contacts.
BLUETONGUEThe various zones for controlling Bluetongue have now been defined. These are difficult to describe because they use roads etc. as boundaries but detailed maps and description of the boundaries are available at:
http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/pdf/declaration-bt-pzcz290907.pdf
When farms straddle a road that is a boundary the whole of the farm is classed as being in the zone. It may be possible to put parts of a holding that is outside the zone as a separate unit with consultation with local Animal Health office.
The movement restrictions between the various FMD and BT zones are available at
http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/movements/index.htm
Defra are worried that farmers are not reporting cases of BT because they feel there is nothing that can be done so why bother. It is still a notifiable disease and there is a need to monitor spread for various trade implications. There are, of course, likely to be welfare considerations with clinically affected cases. These will need to be addressed with veterinary consultation and may involve symptomatic treatment or euthanasia.
The prevalence of the disease in infected herds/flocks is still low with 1:53 and 1:190 being affected on surveillance.
According to the RCVS, 86% of veterinary surgeons, and 92% of veterinary nurses have so far failed to vote in this year's council elections.
There's still time: voting for the RCVS Council and VN Council doesn't close till 2nd May and 28th April respectively.
Voting can be done online: http://www.rcvs.org.uk/Templates/Internal.asp?NodeID=205006, where you can also read each candidate's manifesto.
Life Technologies has announced the launch of a new ELISA test for bluetongue virus (BTV) antibodies.
According to the company, studies have confirmed that the LSI VET Ruminant Bluetongue II-serum ELISA can detect antibodies to BTV in experimentally infected sheep after 6 days, and in cattle after 7-8 days - several days sooner than some other commercially available test kits, including the company's previous ELISA test which the new product has replaced.
Life Technologies asked the UK's Pirbright Institute, the European Union Reference Laboratory for BTV, to conduct a preliminary assessment of the new test. The new test was able to detect antibodies in all 24 BTV reference sera and BTV 26 held by Pirbright, and showed high sensitivity in a longitudinal study of experimentally infected animals.
The Pirbright study also demonstrated that the LSI VET Ruminant Bluetongue II-serum ELISA could detect BTV antibodies in cattle and sheep that had been vaccinated with an inactivated Bluetongue vaccine.
The new test was developed by Life Technologies Animal Health in its research laboratory near Lyon in France and will be available in EU countries via Life Technologies Animal Health distributors according to local regulatory requirements (see www.lifetechnologies.com/lsi-animal-health) for details.
Intervet/Schering-Plough Animal Health has launched its complimentary blood testing service that allows practitioners to investigate one of the main infectious causes of early embryo loss in sheep flocks.
The annual subsidised Barren EweCheck diagnostic scheme is available from 1st December 2009 until 31st March 2010 for breeding ewe flocks. The service establishes whether Toxoplasma gondii is potentially implicated in any empty or aborting ewes.
ISPAH says that data from the 2009 scheme showed that 69% of flocks had been exposed to the toxoplasma parasite at some point before blood sampling. As a result, practitioners were able to give clients receiving a positive diagnosis timely advice on disease control and the benefits of a Toxovax vaccination regime.
Further information and the 2010 Barren EweCheck pads are available directly from the company's Veterinary Support Group by calling 01908 685685.
MSD Animal Health has launched Expertis Udder Health, a farm management tool for veterinary surgeons to better enable them to monitor and improve udder health in dairy cattle.
Expertis was presented to vets at the International Conference on Udder Health and Communication which took place in Utrecht this week.
Expertis Udder Health consists of a software programme together with educational and communication tools to help veterinary surgeons and farmers find the causes of mastitis more easily.
The Expertis Udder Health program consists of four steps: 1. A farm intake questionnaire about setting goals puts the farmer in a central position, and allows for careful listening in order to align with his/her objectives. 2. The data is analyzed, leading to the identification of the right focus points that are needed to identify areas for improvement. 3. These focus points are presented as fact sheets, i.e. a check list of risk factors for mastitis within the focus point. 4. The information is synthesized into an automatic summary of the actual situation, the udder health objectives and an open space to fill in the tailor-made advice to the farmer for improvement of the udder health status on his farm.
Jantijn Swinkels, DVM, Global Technical Director Pharmaceuticals within the Ruminants Business Unit at Merck Animal Health said: "The structured approach offered by Expertis Udder Health takes into account that mastitis is a multifactorial disease and covers all aspects that influence udder health. To save time, the analysis ensures that the focus is on the most important issues, which can differ greatly from farm to farm. The existing services provided within this tool can be used to optimize udder health on the farm".
Rinse Jan Boersma, MSc, Global Director Dairy Cattle at Merck Animal Health added: "We have developed Expertis to support veterinarians and farmers by improving our service level as well as to contribute to good veterinary practices by implementing preventive measures and prudent use of antibiotics."
MSD says that as a consequence of the reduced milk production, discarded milk, veterinary and treatment costs and extra labor costs, mastitis is considered the most important cause of economic loss for dairy operations. Recent data from Sweden indicates an average economic loss of €278 per case of clinical mastitis and of €60 per case of sub-clinical mastitis.*
The Expertis Udder Health program is being rolled out country to country, and will be distributed to veterinary surgeons via local MSD Animal Health representatives.
Reference
* Nielsen C, Østergaard S, Emanuelson U, Andersson H, Berglund B, Strandberg. Economic consequences of mastitis and withdrawal of milk with high somatic cell count in Swedish dairy herds. Animal 2010;4:1758-70
Leading human and animal health organisations – the British Medical Association (BMA), British Dental Association (BDA), British Veterinary Association (BVA) and Royal Pharmaceutical Society (RPS) - have joined forces for the first time to promote a ‘One Health’ approach to ensure responsible guardianship of antibiotics and their proper public use on European Antibiotics Awareness Day tomorrow.
Antibiotics are obviously a vital medicine for both animal and human health, and modern health systems rely on the availability and effectiveness of a range of antimicrobials to treat and prevent infections. Yet inappropriate use – such as prescribing for self-limiting infections, not finishing a prescribed course of antibiotics or habitual prophylactic use in healthy animals to prevent disease - all contribute to the development of resistant bacteria in both humans and animals.
Whilst antibiotic resistance in animals does not perhaps present the greatest immediate existential threat, there is a strong argument for a united message to the public coming from doctors, dentists, chemists and veterinary surgeons.
Quite simply, some 13M households own a pet. Pretty much all of them visit a vet at some stage, and most will be a human patient at some point in their lives. So, what a veterinary surgeon says about the use of antibiotics in animals has the potential to help transform how owners think about them when they come to visit the doctor.
A survey of general practitioner doctors last year found that 90% feel pressured by patients to prescribe antibiotics and 28% have prescribed them several times a week when not sure they are medically necessary. If veterinary surgeons refuse to prescribe them for pets unless medically necessary, explaining that they are a precious resource which can no longer be wasted, it could help relieve the pressure on doctors. The same goes for the importance of compliance; if owners learn the importance of their pet taking the full course, there's a greater chance they'll understand why they need to complete their own course of treatment.
BVA President Sean Wensley said: "Antimicrobial resistance (AMR) is too important an issue for uncoordinated approaches amongst the medical professions. We need to work together to share knowledge and successful approaches, as well as taking responsibility for not just the immediate clinical situations before us, but also for our role in supporting the health and wellbeing of wider society. An effective approach to tackling AMR is about professions and patients working together for the greater good."
BMA board of science Chair Professor Sheila the Baroness Hollins said: "Doctors have expressed significant concern about the threat of a ‘post-antimicrobial age’. It is vital that we see action to improve antimicrobial prescribing across all disciplines. Only by different professionals working together to improve antimicrobial stewardship will we start to address this major public health issue."
BDA President Professor Nairn Wilson said: "All health professionals have a responsibility to draw a line under inappropriate or unnecessary use of antibiotics. One in ten prescriptions in the UK are provided by dentists, so we’re determined to do our bit. We are facing a clear and present danger to public health, and it will only be overcome if we act together."
For further information about EAAD 2015, visit www.ecdc.europa.eu/en/EAAD
To mark EAAD 2015, BVA has produced a range of new posters to promote the responsible use of antibiotics for use in veterinary practices or as a source of information for pet owners which can be found on their website www.bva.co.uk/eaad.
Defra has today published reports from the Health and SafetyExecutive and Professor Brian Spratt, of Imperial College London,into the recent outbreak of Foot and Mouth Disease in Surrey. The report is available here.
Dairy vets will soon be receiving a DVD highlighting the economic losses due to coccidiosis in cattle, from Janssen Animal Health.
According to the company, coccidiosis is a major cause of scouring and poor growth rates in calves yet recent findings have demonstrated that a massive 61 per cent of the economic loss occurs in sub-clinically infected calves that are not showing any obvious clinical signs. Treated calves have been shown to put on 20 per cent more weight than untreated calves1. Coccidiosis infects between 16 and 27 per cent of adult cattle who act as reservoirs of the disease2,3,4,5. This means that most calves are likely to become exposed to the infectious form of the parasite. After the age of 6 months the majority of calves acquire immunity but if they are exposed to a massive challenge before that time due to large numbers of the coccidial oocysts or due to a stress factor, sub-clinical or clinical disease occurs.
The DVD describes the challenges involved in diagnosing coccidiosis and how to interpret faecal oocyst counts, as well as some of the characteristics of sub-clinical infection in calves. The benefits of metaphylactic and preventative approaches to treatment with Vecoxan®, the only anticoccidial drench licensed for beef and dairy cattle at any age, indoors and out, are discussed.
Nigel Underwood from Janssen Animal Health said: "The diagnosis of non-specific scour is problematic at best but it is important that vets have coccidiosis at front of mind when considering the differential diagnosis. Prompt treatment of the whole batch of calves can stop the disease in its tracks and does not interfere with the development of future immunity. We hope this DVD will provide an update on the latest thinking and help increase recognition of this disease."
The DVD will be sent out in February and any vet with an interest in the disease who does not received one before the end of the month should call Janssen on 01494 567555 to request a copy.
Further information is available from Janssen Animal Health, 50-100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG Tel 01494 567555 Fax 01494 567556 Email: ahealth@jacgb.jnj.com
References
322 farmers took part in the survey, 83% of which had a flock of over 100 ewes.
Three quarters of them had experienced abortions in their ewes during both the 2018/2019 and 2019/2020 lambing seasons. Of those that experienced abortions during the 2019/2020 lambing season, a quarter reported that the problem occurred in more than 2% of their flock and 44% of them did not ask their vet to investigate.
Katherine Timms, Ceva Animal Health’s ruminant veterinary advisor said: “Farmers who decide not to investigate why their ewes are aborting may well experience an abortion storm during the following year’s lambing season as Chlamydophila abortus, the bacteria that causes EAE, has the ability to lay latent in ewes until the next pregnancy.
“This means that one infected sheep shedding at lambing has the potential to infect multiple ewes that will almost certainly abort at their next lambing. The consequences can be financially and reproductively devastating for farmers and it’s advisable that vets raise awareness of EAE testing with their clients to help prevent this from happening. Ceva’s Assure Ewe programme offers farmers subsidised farm serology testing for Chlamydia abortus. Aborted ewes can be tested for Chlamydia abortus, ideally from three weeks to three months after lambing.”
Of the 47% of farmers that are not vaccinating against EAE, 57% said they would consider it. Reasons not to vaccinate included farmers believing that they had closed flocks (59%) and EAE not having been diagnosed (57%). Only 20% decided not to vaccinate because of cost and 25% because they did not feel it was worthwhile.
Ceva is continuing its ‘For Flock’s Sake – Vaccinate!’ initiative during 2021 to help raise awareness of EAE and highlight the importance of vaccination. This year, Ceva is also highlighting the importance of testing aborted ewes through its ‘For Flock’s Sake Get Tested’ campaign which encourages the submission of samples to a diagnostic laboratory or blood sampling after lambing has finished.
For more information, visit www.enzooticabortion.co.uk, contact your Ceva Animal Health account manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
Photo: Ewe ewe looking at?
The BVA Animal Welfare Foundation has announced the availability of an updated version of its A3 poultry poster designed to assist veterinary surgeons identify diseases in free-range birds.
Based on information compiled by Victoria Roberts, Honorary Veterinary Surgeon to The Poultry Club, the BVA says the poster provides an invaluable source of information on diseases affecting exhibition chickens, hens, ducks, geese, turkeys, ornamental waterfowl, quail, ornamental pheasants, guinea fowl and peacocks.
The poster details the symptoms of different diseases, the cause, treatment and species affected as well as sections covering common problems and some causes, common diseases by age and life expectancy for the various bird species. A separate highlighted box contains useful tips for veterinary surgeons to pass on to their clients.
Copies of the poster have been circulated to BVA members as an insert in this week’s Veterinary Record. For further copies (free of charge) please ring 020 7636 6541 and ask for the BVA AWF or email bva-awf@bva.co.uk stating your name and postal address, and quoting AWF Poultry Poster.
Pneumonia-induced lung damage could be costing some cattle almost 74kg a year in lost lifetime growth potential with even moderate damage resulting in animals losing 39kg over an 18 month beef finishing system. These are the figures from a major collaborative study between Schering-Plough and Blade Farming, announced yesterday. They suggest that some producers may not be treating cattle pneumonia as effectively as they could. The project also highlights how better abattoir feedback can be used to improve cattle pneumonia management regimes on farm. In the study, 645 commercial beef animals from 15 units were examined at slaughter for evidence of lung damage. Data on carcase weight, age and grade were also collected to allow estimated daily live weight gains (EDLWG) to be recorded. According to project co-ordinator Paul Williams MRCVS from Schering-Plough, the research team recorded a significant level of pneumonia-induced lung damage in the slaughtered cattle. “Nearly half the cattle (48%) examined on the slaughter line had some level of lung damage. But there was also huge variation between units, with all the cattle from one particular farm having damaged lungs,” he said. The researchers also established that the extent of lung damage was strongly associated with reduced EDLWG. “The more lung lobes that are affected, the greater the potential daily liveweight gain loss and those cattle that had the most lung damage experienced a significant reduction in EDLWG of 202g per day throughout their entire lifetime. “For the animals with any degree of lung damage (310 cattle), the average reduction in weight gain over 14 months was 15kg – equivalent to a financial loss of £16.90 per animal based on a live weight price of £1.10 per kg. So the overall loss for this group of animals was potentially £5,239 – money the industry simply cannot afford to lose,” Paul Williams stressed. “In addition, those carcases with lung damage were significantly more likely to have a lower conformation grade and so receive an even lower price,” he explained. Blade Farming managing director Richard Phelps pointed out that the study had convinced him that paying closer attention to minimising pneumonia-induced lung damage could easily make some beef producers an extra £40-£50 an animal. “All the cattle we take look healthy, but I’ve been surprised at the level of undetected lung damage once the animals have been slaughtered. This lung scoring trial work in the abattoir is now helping us assess just how much lung damage diseases like pneumonia can cause. The feedback will be able to help producers reassess early stage rearing issues and be more vigilant. It’s not just grading issues that we are concerned about. Blade Farming consultant veterinary surgeon Rob Drysdale from the Westpoint Veterinary Group stressed that whilst pneumonia prevention should be the number one objective for all cattle producers, having an effective disease treatment protocol in place is increasingly vital – and particularly one that prevents permanent lung damage from occurring. He said: "Pneumonia infections can quickly damage lungs and once this happens the animal will not be able to express its full genetic potential. This means that even if the affected animal survives it is likely to have damaged lungs for the rest of its life, and this will reduce productivity and growth." T
Anyone unable to attend the latest in the increasingly popular BVA Animal Welfare Foundation discussion forums, held in May, can now catch up on the presentations on VETS.TV - the new web TV service currently being piloted by BVA - which can be accessed at www.vets.tv.
All the presentations, including ‘Put your money where your mouth is - can people afford animal welfare in food production', ‘Designer animals or breeding for welfare' and ‘Electric aid or shock collar' as well as the Norman Hayward Fund sponsored session - which included presentations on both the British Equine Veterinary Association (BEVA) and Edinburgh University laminitis studies and the casualty slaughter of sheep - along with the Chair of the BVA:AWF Trustees, Carl Padgett's summary of the day, are now available online to view at your convenience.
Also new on VETS.TV is an interview with Young Vet Network (YVN) senior graduate BVA Council representative, Louisa Rance who talks about the work of the YVN and how it is helping newly qualified vets with the challenges faced after leaving vet school and a series of videos, courtesy of Farmers Weekly, on Bluetongue - what it is, how it is transmitted, the symptoms and vaccination advice.
Mike Gooding, chairman of organiser RAFT Solutions said: “High precision methods are critical to the future of UK livestock farms and their vets.
“The event offers an A-list of international speakers to explain the opportunities presented by precision management techniques that can be applied in practice to any livestock enterprise.”
One example is early detection of sub-optimal animal performance and timely intervention, which is included in the session: ‘Big Tech and what it offers Precision Livestock Farming’.
The session will explore the use of data to empower precision decisions with Prof Jasmeet Kaler from University of Nottingham.
There will also be an open debate about consumer perceptions, legislative governance, and impacts upon or opportunities for farmers and vets.
Mike added: "All conference-goers, whether attending in person or on-line, will be challenged to adapt their thinking and focus on post-conference changes for the better."
A choice of one- or two-day tickets is available at connectmyevent.com/raftsolutionsltd/plfip2021.
Novartis Animal Health has launched 'The Wormer Decision Tree', an online tool to help veterinary surgeons in giving sheep farmers the most up-to-date advice about worming.
Lesley Stubbings, SCOPS representative and Independent Sheep Consultant said: “Choosing the right wormer group is hugely important and there remains much confusion especially when it comes to anthelmintic resistance.
“Worms, including resistant and multi-resistant species, are threatening the productivity of sheep farms. However with a well-thought-out worming strategy that uses both the new wormer groups, in association with existing wormers, it is possible to slow resistance.”
Results of the Farming Against Wormer Resistance (FAWR) campaign survey, conducted in 2013, revealed growing concern about wormer resistance among farmers - but confusion about the best course of action to take.
Fiona Anderson, Novartis Animal Health Veterinary Manager said: "This tool has been developed adhering to SCOPS principles and is designed to ensure a consistent responsible approach is used when prescribing anthelmintics.
"Available only to SQPs and vets, it will be a valuable tool to train new staff and use with farmers, to explain which of the five drench classes are appropriate for particular sheep groups at specific times of year."
The Novartis Wormer Decision Tree asks three key questions: the type of sheep being dosed, the purpose of the dose, and the farm's resistance status. It then produces a recommendation of the required active ingredient, along with more detailed information to support the recommendation. There is also a calculator which provides a dose rate and cost per dose based upon the recommendation.
To use the decision tree, you must first register on the Novartis Farm Animal Health website: www.farmanimalhealth.co.uk. Then head here: www.farmanimalhealth.co.uk/wormerdecisiontree
Intervet/Schering-Plough Animal Health has announced that it has received marketing authorization from the European Commission for a single-shot vaccination schedule of its Porcilis PCV vaccine against porcine circovirus type 2 (PCV2) infections.
The new approval allows vaccination with 1 dose of 2 ml in pigs from an age of 3 weeks onwards (known as the 1 - 2 - 3 approach) in the case of low to medium levels of maternal antibodies against PCV2, and also to include reduction of mortality as an additional indication. This new single-shot application for Porcilis PCV offers additional flexibility over the currently available dosage scheme of this vaccine, which has been available in Europe since April 2009.
Intervet/Schering Plough says the major characteristics of Porcilis PCV are that: (1) it contains the Cap-2 subunit antigen coded by ORF2 and therefore induces strong immunity against PCV2 infection; (2) it is combined with XSolve, an adjuvant offering immunity until the end of the finishing period; and (3) is able to break through of all levels of maternally-derived antibodies in piglets depending on the vaccination schedule used.
The company adds that one single dose of Porcilis PCV has been demonstrated to induce both humoral and cell-mediated responses against PCV2, despite the presence of low to medium levels of maternal antibodies. According to a recent study published in Vaccine, the immunity induced by a single dose of the vaccine resulted in reductions of viremia, viral shedding and viral load in tissues in vaccinated pigs as compared to controls. Field trials have also demonstrated that vaccination of pigs at 3 weeks of age or older reduces the presence of virus load in the blood and reduces weight loss associated with PCV2 infection during the fattening period.
Infection with PCV2 is known to cause a variety of syndromes in pigs, together known as Porcine Circo Virus Disease (PCVD). Symptoms may include clinical signs such as weight loss or failure to grow, enlarged lymph nodes, difficulty in breathing, pale skin and jaundice.
The World Veterinary Poultry Association (WVPA) has announced that nominations are now open for its Young Poultry Veterinarian of the Year 2015 Award, sponsored by Zoetis.
The award, now in its fourth year, is open to qualified poultry veterinarians who are under the age of 35 on January 1, 2015. The winner will be selected by a global panel of judges and will receive a USD$5,000 contribution towards attending international scientific or continued professional development meetings.
The WVPA is calling for nominations to be made on behalf of young veterinarians who have excellent poultry diagnostic and advisory skills, are effective communicators and transferors of their knowledge and can demonstrate a real passion for their industry.
Nigel Horrox, vice president of the WVPA said: "We continue to be impressed by the calibre of entries for this award, and we are confident that this year will be no exception.
"We are looking for an individual who is not only invaluable to their local poultry industry, but who consistently goes above and beyond the call of duty and is a credit to their profession."
Hector Badillo, group director of global marketing at Zoetis, said the contribution made by young poultry veterinarians is vital to the future of the industry. "We are proud to support this award, which recognises top new talent in the global poultry industry and the outstanding contribution made by an individual."
Entries for the award are to be made via the dedicated website: www.wvpa-award.com. Nominees/applicants are asked to describe in 500 words or less their role and achievements in the industry and why they feel they should win the award. The award will be presented at the XIX Congress of the World Veterinary Poultry Association, Cape Town, South Africa, September 7-11, 2015.
Closing date for entries is March 31, 2015.
The University of Bristol's School of Veterinary Sciences at Langford has opened a £2 million state-of-the-art dairy farm.
Wyndhurst Farm's dairy unit has undergone a major rebuild in order to provide a world-class practical teaching environment for around 600 veterinary students, as well as a facility that can be used to support research and the continual professional development of veterinary surgeons, farmers and others involved in the dairy industry locally, nationally and internationally. Professor Jo Price, Head of the School of Veterinary Sciences, said: "This is an exciting time for the Vet School. The new dairy unit will enable our undergraduate and postgraduate students to be taught in a world-class facility. It will provide the best standards of animal welfare for our dairy herd and will support our research on the prevention and treatment of diseases of farm animals."The farm, which is approximately 250 acres, includes numerous features to ensure high welfare standards. The dairy herd will be housed in deep sand bedded cubicles, with parts of the floors covered in soft rubber to protect the cows' feet and when housed cows will be fed a total mixed ration using grass, maize and whole crop wheat silages grown on the farm.Since the new facility has been built the farm's herd of Pedigree Holstein cows have increased in number from 110 to 180 cows and will soon reach 200, with each cow giving over 9,000 litres of milk per year. The farm also has a newly established breeding flock of 100 New Zealand Romney ewes. Since 2010 it has been managed by Velcourt Farm Management.
Bimeda UK has announced that Endofluke 100mg Oral Suspension has been approved for use in dairy cows, with a milk withdrawal period of 45 days + 48 hours.
Endofluke is licensed for use in cattle and sheep and its active ingredient, triclabendazole (100mg/ml) kills all three stages of liver fluke.
Bimeda UK Sales Manager, Andrew Lane said: "This is great news for the UK's dairy farmers. Endofluke has long been favoured by British & Northern Irish farmers as a liver fluke treatment, due to its ability to offer complete chronic and acute fluke control in both sheep and cattle. It is proven to be highly effective against early-immature, immature and adult liver fluke, and to now be able to extend these benefits to dairy cows, is fantastic news for the UK's dairy farmers."
Endofluke is a POM-VPS product.
For more information, visit www.bimeda.co.uk or contact Bimeda UK Sales Manager Andrew Lane, on alane@bimeda.com or on 07917 208524.
CEVA Animal Health is supplying a free, multi-dose injector gun with a self-sterilising needle system, with the purchase of bulk quantities of its luteolytic and uterotonic prostaglandin Enzaprost, while stocks last.
According to the company, the use of naturally occurring prostaglandins such as Enzaprost play an important role in any fertility management programme, working by causing lysis of the corpus luteum. Enzaprost can be used to control the timing of oestrus and synchronisation for AI; for the treatment of sub-oestrus or silent heat; for the induction of abortion up to day 120; for the induction of parturition and as an aid in the treatment of chronic metritis or pyometra where there is a functional or persistent corpus luteum. Natural prostaglandins also have a uterotonic effect which may be useful in the treatment of 'dirty' cows.
CEVA says any multi-cow injection programme has its risks, and that experience has shown that one in 250,000 injections can result in clostridial infection. Invariably this occurs in sequential animals, with the causal agent found in the bottle as a result of inadvertent needle contamination. Multi-dose syringes reduce the number of needle punctures into a bottle and the Sterimatic caps clean the needle before and after each injection helping to minimise the risk of infection. One Sterimatic cap can be used for 72 hours or up to 100 injections. The covered needle also provides increased safety for the operator, resulting in fewer needle stick and scratch injuries.
To find out how you can receive a free multi-dose injector with the Sterimatic needle protector system, which includes five caps and one needle protector, please contact your local CEVA territory manager
For copies of CEVA's fertility newsletters or for further product information please contact the large animal sales team or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
The review coincided with a move last month from RUMA, the agricultural and food industry alliance which promotes responsible use of medicines in farm animals, to align with the EMA position.
The announcement means that under PVS guidelines, fluoroquinolones, 3rd and 4th generation cephalosporins and colistin will retain Class 3 status. This means they are only used when no other options are available and when supported by laboratory sensitivity testing – or exceptionally when all other options have failed.
Class 1 antibiotics form the standard prescribing list within responsible use guidelines and Class 2 are used only when sensitivity tests or clinical experience proves standard antibiotics are not effective. In all treatment decisions the health and welfare of the pigs must always take priority.
Betalactams with betalactamase inhibitors (clavulanic acid) were previously in the highest priority Class 3 but in light of the list defined by the EMA, which has been adopted by the Veterinary Medicines Directorate as well as RUMA, the PVS has reassessed the risk and moved them to Class 2 to align them with plain betalactams. This means they are still subject to voluntary restrictions, but their use would not necessarily be only as a last resort.
PVS president Mark White said that despite the ongoing review process and the potential to reclassify certain products, the Society’s underlying principles remain unchanged: "The total amount of all antibiotics used on pig farms to treat and prevent disease should be minimised, and the types of antibiotics used in pigs should be considered in light of the implications for antibiotic resistance challenges in both pigs and man.
"This policy is proving successful with AHDB Pork’s electronic pig medicine book (e-MB) recently showing that use of colistin appears to have fallen by over 70% in 2016 following its move to a Class 3 antibiotic in late 2015.
"We must also continue to be alert to the possibility of cross resistance, even in older antibiotics that have little or no use in humans. Risk must be acknowledged where it exists and overall reductions are still imperative."
RUMA has welcomed the review and alignment from the PVS. Secretary General John FitzGerald said: "Farmers and vets need boundaries within which to operate and clear objectives to meet, and we would urge all supply chains, from farmer to retailer, to align with the sector position on best practice use of antibiotics, as defined by each sector’s professional veterinary organisation."
Defra has announced that Great Britain is to be declared bluetongue-free from 5th July 2011.
From this date, bluetongue susceptible species being exported from Great Britain will no longer need to be vaccinated against BTV8 or meet any of the other 'Annex III conditions.
However, the current EU Bluetongue Directive only allows bluetongue vaccination within a protection zone, so from 5th July vaccination will no longer be permitted in Great Britain.
The British Veterinary Association is supporting Defra to lobby for these rules to be changed to allow vaccination in bluetongue areas.
Harvey Locke, BVA President, said: "The move to bluetongue freedom is thanks to the excellent partnership between government, farmers and vets across Great Britain. It is a tremendous achievement to turn the situation around from the outbreak in 2007 to freedom in 2011.
"We are disappointed that changes to the EU Directive to allow vaccination to continue could not be made before the deadline and we will continue to work with Defra to try to secure this change as soon as possible to allow vets and farmers to make the right choice to protect their herds.
"Those farmers and vets that wish to vaccinate must do so before the 5th July.
"The BVA would reiterate the message to farmers to source stock responsibly to help avoid a future outbreak."